A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Clinical trial NCT02976779 · COMPLETED

Trial details

NCT number: NCT02976779
Sponsor: One World Cannabis Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Study for Future Treatment of Psoriasis

Start date: 2017-02-03
Primary completion: 2019-01-25
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.